| Company Name: |
Hefei Molake Biotechnology Co., Ltd.
|
| Tel: |
0551-66336380 18956014586 |
| Email: |
983438788@qq.com |
| Products Intro: |
Product Name:Ethambutol-d8
CAS:1129526-23-3
Purity:98% Package:10mg,100mg,1g,10g
|
| Company Name: |
QUALITY CONTROL SOLUTIONS LTD.
|
| Tel: |
+86-0755-66853366 +86-13670046396 |
| Email: |
export03@qcsrm.com |
| Products Intro: |
Product Name:Ethambutol-d8
CAS:1129526-23-3
Purity:95% HPLC Package:10MG;25MG;50MG;100MG
|
| Company Name: |
Shanghai isotope chemical co.,ltd
|
| Tel: |
021-51600108 13062666369 |
| Email: |
sales@isotopechem.com |
| Products Intro: |
Product Name:Ethambutol-d8
CAS:1129526-23-3
Purity:1mg Package:1mg Remarks:RMCE76129-1mg
|
EthaMbutol-d8 manufacturers
- Ethambutol-d8
-
- $0.00 / 1mg
-
2025-08-21
- CAS:1129526-23-3
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | EthaMbutol-d8 Basic information |
| | EthaMbutol-d8 Chemical Properties |
| | EthaMbutol-d8 Usage And Synthesis |
| Uses | Ethambutol-d8 is deuterium labeled Ethambutol. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Ethambutol. Tuberculosis (Edinb), 2008. 88(2): p. 102-5. DOI:10.1016/S1472-9792(08)70008-8
[3] Rastogi, N., V. Labrousse, and K.S. Goh, In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol, 1996. 33(3): p. 167-75. DOI:10.1007/s002849900095
[4] Kaur, D. and G.K. Khuller, In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria. Int J Antimicrob Agents, 2001. 17(1): p. 51-5. DOI:10.1016/s0924-8579(00)00308-3 |
| | EthaMbutol-d8 Preparation Products And Raw materials |
|